Nadine Houede

Title: Nadine Houede: Innovator in Cancer Treatment

Introduction

Nadine Houede is a prominent inventor based in Beychac et Cailleau, France. She has made significant contributions to the field of medicine, particularly in the treatment of cancer. Her innovative approach focuses on optimizing the dosage of efavirenz, a medication traditionally used for treating AIDS, for cancer therapy.

Latest Patents

Nadine Houede holds a patent for her invention titled "Increased dosage of efavirenz for the treatment of cancer." This invention is based on the discovery that a higher daily dose of efavirenz can be more effective in treating cancer compared to the standard dosage used for AIDS. The patent outlines the use of efavirenz in preparing a medicament intended for cancer treatment, emphasizing a daily dose of at least 1800 mg, particularly between 1800 and 2200 mg. It also discusses the administration of efavirenz at a dose that generates a plasma concentration superior to 3000 ng/ml, ensuring optimized treatment for patients.

Career Highlights

Nadine has dedicated her career to advancing medical treatments through innovative research. Her work has the potential to change the landscape of cancer therapy, providing new hope for patients. She is associated with Alienor Farma, where she continues to develop her groundbreaking ideas.

Collaborations

Nadine collaborates with notable professionals in her field, including Pier Vincenzo Piazza and Audrey Laroche-Clary. These partnerships enhance her research and contribute to the development of effective cancer treatments.

Conclusion

Nadine Houede's innovative work in optimizing efavirenz dosage for cancer treatment showcases her commitment to improving patient outcomes. Her contributions to the medical field are invaluable and highlight the importance of continued research and innovation in healthcare.